Juanjuan Qin

Title: Juanjuan Qin: Innovator in Pharmaceutical Chemistry

Introduction

Juanjuan Qin is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating central nervous system diseases. With a total of 2 patents, his work showcases innovative approaches to drug design and application.

Latest Patents

Juanjuan Qin's latest patents include two significant inventions. The first patent involves 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, which are disclosed along with their preparation methods and uses. These compounds are designed to treat and prevent central nervous system diseases associated with TSPO functional disorders. The second patent focuses on 1-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives. These compounds exhibit dual activities as a 5-hydroxytryptamine 1A receptor ligand and a selective serotonin reuptake inhibitor, providing potential therapeutic benefits for nervous system diseases related to 5-hydroxytryptamine system dysfunction.

Career Highlights

Juanjuan Qin has worked at the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, in China. His role at this prestigious institution has allowed him to engage in cutting-edge research and development in the pharmaceutical field.

Collaborations

Throughout his career, Juanjuan has collaborated with notable colleagues, including Rifang Yang and Yunfeng Li. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Juanjuan Qin's innovative work in pharmaceutical chemistry highlights his commitment to addressing critical health challenges through his inventions. His contributions to the field are significant and continue to impact the development of new therapeutic options.